Drug Programs Evaluation SOW ver 3 5new.pdf

Version 3 5-12-2021

SOW Drug Treatment Program Evaluation Page 1 of 15

FEDERAL BUREAU OF PRISONS (BOP) STATEMENT OF WORK (SOW):

DRUG ABUSE PROGRAMS OUTCOMES STUDY

1.0 GENERAL

1.1 BACKGROUND

Substance use disorders represent a serious national crisis, and a significant percentage of people with histories of substance misuse are involved in the criminal justice system. It is estimated that 60% of inmates incarcerated in the federal justice system met the diagnostic criteria for a substance use disorder at the time of their arrest.

The Federal Bureau of Prisons (BOP) is responsible for providing substance use treatment to federal inmates. Pursuant to 18 U.S.C. § 3621, BOP is required to make available appropriate substance use treatment for qualified inmates. BOP’s portfolio of drug programs includes a Drug Education program and three evidence-based treatment programs: the Residential Drug Abuse Program (RDAP), the Non-Residential Drug Abuse Program (NRDAP), and the Medication Assisted Treatment (MAT) Program. These programs are designed to assist inmates in examining the impact of substance use on their lives, commit to and maintain recovery from substance misuse, and address associated criminogenic risk factors.

The BOP’s drug treatment programs are managed in the context of the hierarchical structure of agency operations. A Psychology Services department (under the supervision of the Chief Psychologist) at each institution is responsible for delivery of substance use treatment services (with the exception of medications prescribed to MAT Program participants), with staff who are specifically funded and allocated for this purpose. Drug Abuse Program Coordinators are doctoral-level psychologists who manage and coordinate drug treatment programs and supervise Drug Treatment Specialists in the delivery of assessment and treatment services.

Discipline-specific subject matter experts (SMEs) are available for consultation at the Regional level. The Psychology Services Branch (PSB) in BOP’s Central Office is responsible for policy and protocol development, managing agency infrastructure to enable effective implementation and operation of drug treatment programs, and providing technical support.

BOP has implemented a number of strategies to ensure Program Fidelity. Drug treatment programs utilize standardized curricula and protocols are that have been thoroughly vetted by PSB SMEs. This ensures all participants in a particular program or activity receive the same content, regardless of location. The Bureau of Prisons has implemented policy requirements to ensure the use and delivery of standardized curricula/models.

The First Step Act of 2018 directs the Attorney General to conduct “ongoing research and data analysis” on:

“(A) evidence-based recidivism reduction programs relating to the use of prisoner risk and needs assessment tools;

“(B) the most effective and efficient uses of such programs;

“(C) which evidence-based recidivism reduction programs are the most effective at reducing recidivism, and the type, amount, and intensity of programming that most effectively reduces the risk of recidivism” [First Step Act of 2018, 2018, 18 U.S.C.

§ 3621(b)(3)].

SOW Drug Treatment Program Evaluation Page 2 of 15

Program evaluation is important tool for informed decision-making with respect to the efficient allocation of resources, treatment efficacy, and accountability to stakeholders.

1.2 SCOPE

BOP seeks a Contractor experienced in conducting psychosocial intervention outcome research to evaluate its suite of drug programs, individually and collectively. Variables of interest in include symptom reduction, institutional adjustment of participants, misconduct/criminal recidivism, and indicators of post-release adjustment. The Contractor shall propose the research design, obtain approval from BOP’s Institutional Review Board (IRB), collect data, conduct analyses, and report findings and recommendations.

1.3 OBJECTIVE

BOP seeks to study and optimize its portfolio of drug programs in terms of fidelity and efficacy.

Results and recommendations will be used to make improvements in curricula, treatment protocols, program operations, and oversight.

1.4 APPLICABLE DOCUMENTS

1.4.1 COMPLIANCE DOCUMENTS

• Program Statement 1070.07, Research (https://www.bop.gov/resources/research_and_reports.jsp)

• Department of Justice Regulations for Protecting Human Subjects (28 CFR 46) (https://www.bop.gov/resources/pdfs/ore28cfr46.pdf)

1.4.2 REFERENCE DOCUMENTS

The following agency policies may be helpful to the Contractor in performing the work described in this document, and may be accessed via the BOP’s public website:

https://www.bop.gov/PublicInfo/execute/policysearch?todo=query&series=5000

• Program Statement 5330.11 CN-1, Psychology Treatment Programs

• Program Statement 5331.01 CN-2, Early Release Procedures Under 18 U.S.C. §

3621(e)

• Program Statement 5310.17, Psychology Services Manual

Written reports shall be written using guidelines outlined in the style guide published by the American Psychological Association:

American Psychological Association. (2020). Publication manual of the American Psychological

Association (7th ed.). Washington, DC: Author.

2.0 SPECIFIC REQUIREMENTS/TASKS

Each of the following programs will be evaluated individually:

• Drug Education

• Non-Residential Drug Abuse Program (NRDAP)

• Residential Drug Abuse Program (RDAP)

• Medication Assisted Treatment Program (MAT Program)

In addition, the Contractor shall design, propose, and complete an evaluation of outcomes related to collective program participation (i.e., inmate participation in two or more drug programs).

https://www.bop.gov/resources/research_and_reports.jsp https://www.bop.gov/PublicInfo/execute/policysearch?todo=query&series=5000

SOW Drug Treatment Program Evaluation Page 3 of 15

2.1 TASK ONE. Evaluation: Drug Education Program

Drug Education is designed to encourage sentenced inmates with a history of drug use to review the consequences of drug use and consider the benefits of seeking treatment. Drug Education is a 12-15 hour psychoeducational program that takes the inmate through the cycle of drug use and crime, offers a compelling perspective on the consequences of continued drug use, and introduces the inmate to available treatment options. Drug Education is offered at every BOP institution.

On average, 23,000 inmates participate in Drug Education each year. Inmates are required to complete Drug Education if they meet any of the following criteria;

• There is evidence that alcohol or other drug use contributed to the commission of the offense;

• Alcohol or other drug use was a reason for violation either of supervised release (including parole) or BOP community placement [i.e., placement in a Residential Reentry Center (RRC, sometimes called “halfway house”) or home confinement];

• There was a recommendation for drug programming during incarceration by the sentencing judge;

• There is evidence of a history of alcohol or other drug use.

2.1.1 The Contractor shall submit a detailed proposed research design to evaluate BOP’s Drug Education Program. Variables of interest may include:

• Participant knowledge acquisition, as measured by pre- and post-test scores

• Extent to which participants are more likely than non-participants to request drug treatment

Other variables of interest may be identified and jointly approved for inclusion by the Contractor and BOP. Following approval of the initial research design by PSB, the Contractor shall submit the design and all required applications to BOP’s IRB for review and approval, in a format consistent with guidelines outlined in Program Statement 1070.07, Research. The research design shall be modified as required by the IRB.

2.1.2 Following final approval by PSB and IRB, the Contractor shall collect the necessary data according to the approved research design. Data collection may include, but is not limited to, any of the following activities:

• Obtaining data from BOP staff facilitating the Drug Education groups or involved in program oversight (e.g., any pre-group and post-group measure data or data related to fidelity of the program at a specific facility);

• Obtaining pre-existing data from the BOP’s Office of Research and Evaluation and RSD (to be de-identified in any dataset removed from BOP premises). Data such as these may include disciplinary infraction information, security level, or other information which might aid in the research process and contribute to descriptive statistics and findings.

2.1.3 The Contractor shall conduct data analysis consistent with the proposed data analytic procedures outlined in the approved research design. Completed analyses will be examined by ORE. ORE may submit recommendations for modifications or additional analyses to PSB. If PSB concurs, the Contractor will complete additional data analyses as directed.

SOW Drug Treatment Program Evaluation Page 4 of 15

2.1.4 The Contractor will submit a written summary of the evaluation, consistent with industry standards and standards of scholarly writing (American Psychological Association, 2020). The report shall include the following components:

• Title page

• Abstract

• Introduction

• Methods

• Results

• Discussion

• References

2.1.5 The Contractor shall present findings to PSB in either a virtual or face-to-face meeting within 30 days of submission of the written summary of the evaluation.

2.1.6 With IRB prior approval, preparation of manuscript(s) in collaboration with PSB staff for submission for publication in peer-reviewed journals and/or correctional magazines.

2.1.7. Written information for non-scholarly audiences, including stakeholders, that demonstrate the research findings and draw on the Contractor’s experience with and knowledge of the drug treatment field.

2.2 TASK TWO. Evaluation: Non-Residential Drug Abuse Program

The Non-Residential Drug Abuse Program (NRDAP) is available to inmates at every BOP institution. The purpose of NRDAP is to afford all inmates with a self-reported drug problem the opportunity to receive substance use treatment, guided by an individualized treatment plan.

The cognitive-behavioral treatment protocol is designed to be completed over the course of 12- 14 weeks of group therapy. On average, over 11,000 inmates participate in NRDAP each year.

2.2.1 The Contractor shall submit a detailed proposed research design to evaluate BOP’s NRDAP. Variables of interest may include:

• Assessment of inmate satisfaction with treatment

• Therapist variables (e.g., demographic, professional, diversity)

• Rates of comorbid mental health diagnosis among program participants

• Knowledge/skills acquisition

• Treatment retention

• Substance use disorder symptom reduction

• Institutional adjustment following program completion (e.g., misconduct, work assignment)

• Timing of treatment

• Gender/race/cultural differences

Other variables of interest may be identified and jointly approved for inclusion by the Contractor and BOP. Following approval of the initial research design by PSB, the Contractor shall submit the design and all required applications to BOP’s IRB for review and approval in a format consistent with guidelines outlined in Program Statement 1070.07, Research. The research design shall be modified as required by the IRB.

SOW Drug Treatment Program Evaluation Page 5 of 15

2.2.2 Following final approval by PSB and IRB, the Contractor shall collect the necessary data according to the approved research design. Data collection may include, but is not limited to, any of the following activities:

• Development and administration of pre- and post-intervention measures;

• Obtaining data from BOP staff facilitating NRDAP treatment or from staff involved in program oversight (e.g., any pre-group and post-group measure data or data related to fidelity of the program at a specific facility);

• Obtaining pre-existing data from the BOP’s Office of Research and Evaluation and RSD (to be de-identified in any dataset removed from BOP premises). Data such as these

2.2.3 The Contractor shall conduct data analysis consistent with the proposed data analytic

ORE. ORE may submit recommendations for modifications or additional analyses to PSB. If PSB concurs, the Contractor will complete additional data analyses as directed.

2.2.4 The Contractor will submit a written summary of the evaluation, consistent with industry standards and standards of scholarly writing (American Psychological Association, 2020). The report shall include the following components:

• Title page

• Abstract

• Introduction

• Methods

• Results

2.2.5 The Contractor shall present findings to PSB in either a virtual or face-to-face meeting

2.2.6 With IRB prior approval, preparation of manuscript(s) in collaboration with PSB staff for submission for publication in peer-reviewed journals and/or correctional magazines.

2.2.7. Written information for non-scholarly audiences, including stakeholders, that demonstrate

SOW Drug Treatment Program Evaluation Page 6 of 15

2.3 TASK THREE. Evaluation: Residential Drug Abuse Program

The Residential Drug Abuse Program (RDAP) is designed for the inmate who volunteers for treatment, has a diagnosable and verifiable substance use disorder, and is able to participate in all program components. To successfully complete RDAP, inmates must complete each of the following components:

a. Unit-based component. Inmates must complete a course of treatment activities facilitated by drug treatment staff in a treatment unit set apart from the general prison population. This component is a minimum of 500 hours of face-to-face treatment over the course of 9 months. As of April 6, 2021, the BOP operates 83 RDAP treatment units at 71 BOP locations.

b. Follow-up services. If time allows between completion of the unit-based component of RDAP and transfer to community placement (i.e., placement in a RRC or home confinement), inmates must participate in the follow-up services to the unit-based component of RDAP. These services are provided at all BOP institutions.

c. Community treatment services. Inmates who have completed the unit-based component of RDAP and (when appropriate) the follow-up treatment component are transferred to community placement to complete the transitional component of RDAP. These services are intended to facilitate the inmate’s transition from incarceration to the community. Treatment is provided by a network of contracted substance use treatment providers.

Over 11,000 inmates participate in RDAP each year.

2.3.1 The Contractor shall submit a detailed proposed research design to evaluate BOP’s RDAP. Variables of interest may include:

• Assessment of inmate satisfaction with treatment

• Therapist variables (e.g., demographic, professional, diversity)

• Rates of comorbid mental health diagnosis among program participants

• Substance use disorder symptom reduction

• Institutional adjustment following program completion (e.g., misconduct, work assignment)

• Adjustment to community placement

• Knowledge/skills acquisition

• Impact of early release eligibility [pursuant to 18 U.S.C. § 3621(e)] on program retention and outcomes

• Post-release employment

• Post-release recidivism

• Relapse

• Special programs outcomes (i.e., Dual-Diagnosis RDAP, Spanish RDAP) and BOP. Following approval of the initial research design by the Psychology Services Branch (PSB), the Contractor shall submit the design and all required applications to BOP’s IRB for review and approval. The research design shall be modified as required by the IRB.

2.3.2 Following final approval by PSB and IRB, the Contractor shall collect the necessary data according to the approved research design. Data collection may include, but is not limited to, any of the following activities:

• Development and administration of pre- and post-intervention measures;

SOW Drug Treatment Program Evaluation Page 7 of 15

• Obtaining data from BOP staff facilitating RDAP treatment or staff responsible for program oversight (e.g., any pre-group and post-group measure data or data related to fidelity of the program at a specific facility);

• Obtaining pre-existing data from the BOP’s Office of Research and Evaluation and RSD (to be de-identified in any dataset removed from BOP premises). Data such as these

2.3.3 The Contractor shall conduct data analysis consistent with the proposed data analytic

ORE. ORE may submit recommendations for modifications or additional analyses to PSB. If PSB concurs, the Contractor will complete additional data analyses as directed.

2.3.4 The Contractor will submit a written summary of the evaluation, consistent with industry standards and standards of scholarly writing (American Psychological Association, 2020). The report shall include the following components:

• Title page

• Abstract

• Introduction

• Methods

• Results

2.3.5 The Contractor shall present findings to PSB in either a virtual or face-to-face meeting

2.3.6 With IRB prior approval, preparation of manuscript(s) in collaboration with PSB staff for submission for publication in peer-reviewed journals and/or correctional magazines.

2.3.7. Written information for non-scholarly audiences, including stakeholders, that demonstrate

2.4 TASK FOUR. Evaluation: Medication Assisted Treatment Program BOP began implementing Medication Assisted Treatment (MAT) in 2018, with a focus on inmates with histories of opioid use disorders who were nearing community placement. The First Step Act (2018) directed BOP to expand assessment and treatment of inmates with opioid use disorder. This expansion includes increasing the availability of MAT to all inmates with a clinical need for treatment, implementation of MAT Programs at all facilities to provide individualized treatment, and establishment of several certified Opioid Treatment Programs (OTPs).

2.4.1 The Contractor shall submit a detailed proposed research design to evaluate implementation and outcome for BOP’s MAT Program. Variables of interest may include:

• Accurate patient identification and connection with treatment

• Efficiency of joint referral and screening process (Psychology Services and Health

Services)

• Assessment of inmate satisfaction with treatment

SOW Drug Treatment Program Evaluation Page 8 of 15

• Rates of comorbid mental health diagnosis among program participants

• Adjustment to community placement

• Opioid use disorder symptom reduction

• Post-release employment

• Post-release recidivism

• Relapse

(PSB), the Contractor shall submit the design and all required applications to BOP’s IRB for review and approval, in a format consistent with guidelines outlined in Program Statement 1070.07, Research. The research design shall be modified as required by the IRB.

2.4.2 Following final approval by PSB and IRB, the Contractor shall collect the necessary data according to the approved research design. Data collection may include, but is not limited to, any of the following activities:

• Development and administration of pre- and post-intervention measures;

• Obtaining data from BOP staff providing MAT or involved in program oversight (e.g., any pre-group and post-group measure data or data related to fidelity of the program at a specific facility);

• Obtaining pre-existing data from the BOP’s Office of Research and Evaluation and RSD (to be de-identified in any dataset removed from BOP premises). Data such as these

2.4.3 The Contractor shall conduct data analysis consistent with the proposed data analytic

ORE. ORE may submit recommendations for modifications or additional analyses to PSB. If PSB concurs, the Contractor will complete additional data analyses as directed.

2.4.4 The Contractor will submit a written summary of the evaluation, consistent with industry standards and standards of scholarly writing (American Psychological Association, 2020). The report shall include the following components:

• Title page

• Abstract

• Introduction

• Methods

• Results

2.4.5 The Contractor shall present findings to PSB in either a virtual or face-to-face meeting

2.4.6 With IRB prior approval, preparation of manuscript(s) in collaboration with PSB staff for submission for publication in peer-reviewed journals and/or correctional magazines.

SOW Drug Treatment Program Evaluation Page 9 of 15

2.4.7. Written information for non-scholarly audiences, including stakeholders, that demonstrate

2.5 TASK FIVE. Evaluation: Multiple Program Participation

A substantial percentage of inmates participate in more than BOP substance use program;

consequently, it is necessary to consider the interactional and additive effects of program participation.

2.5.1 The Contractor shall submit a detailed proposed research design to evaluate outcomes associated with participation in more than one BOP substance use program. Variables of interest may include:

• Accurate patient identification and connection with treatment services

• Assessment of inmate satisfaction with treatment

• Rates of co-occurring mental illness diagnosis among drug treatment program participants

• Timing of treatment

• Institutional adjustment

• Adjustment to community placement

• Substance use disorder symptom reduction

• Post-release employment

• Post-release recidivism

• Relapse

Other variables of interest may be identified and jointly approved for inclusion by the contractor

(PSB), the Contractor shall submit the design and all required applications to BOP’s IRB for review and approval, in a format consistent with guidelines outlined in Program Statement 1070.07, Research. The research design shall be modified as required by the IRB.

2.5.2 Following final approval by PSB and IRB, the contractor shall collect the necessary data according to the approved research design. Data collection may include, but is not limited to, any of the following activities:

• Development and administration of pre- and post-intervention measures;

• Obtaining data from BOP staff involved in drug treatment (e.g., any pre-group and post-group measure data or data related to fidelity of the program at a specific facility);

• Obtaining pre-existing data from the BOP’s Office of Research and Evaluation and RSD

(to be de-identified in any dataset removed from BOP premises). Data such as these

2.5.3 The Contractor shall conduct data analysis consistent with the proposed data analytic

ORE. ORE may submit recommendations for modifications or additional analyses to PSB. If PSB concurs, the contractor will complete additional data analyses as directed.

SOW Drug Treatment Program Evaluation Page 10 of 15

2.5.4 The Contractor will submit a written summary of the evaluation, consistent with industry standards and standards of scholarly writing (American Psychological Association, 2020). The report shall include the following components:

• Title page

• Abstract

• Introduction

• Methods

• Results

2.5.5 The Contractor shall present findings to PSB in either a virtual or face-to-face meeting

2.5.6 With IRB prior approval, preparation of manuscript(s) in collaboration with PSB staff for submission for publication in peer-reviewed journals and/or correctional magazines.

2.5.7. Written information for non-scholarly audiences, including stakeholders, that demonstrate

3.0 CONTRACTOR PERSONNEL

3.1 QUALIFIED PERSONNEL

The Contractor shall provide qualified personnel to perform all requirements specified in this SOW. The Contractor must specifically identify the individual(s) that will be performing these services under any subsequent contract award. The Contractor must provide proof that their candidate(s) meet all qualifications. The candidate(s)'s name and qualifications must be submitted at the time the quote is submitted. Contractors must submit with their quote a resume, photocopies of documents evidencing education, training, and experience. The Contractor shall possess the necessary skills, abilities, and credentials to develop research methodology specific to cognitive behavioral drug treatment programs in correctional environments. Professional staff shall only perform those duties for which their position, certification and degree dictates.

• The Contractor must have achieved education at the doctoral level (e.g., PhD, PsyD).

• The Contractor must demonstrate experience, knowledge and familiarity with the following: program evaluation, cognitive behavioral therapy, the Risk-Need-Responsivity model, behavioral change programs, and correctional systems. This must have been gained on the national level.

• The Contractor must have experience conducting research on psychological topics as shown by a body of published work in peer-reviewed journals.

• The Contractor must have experience conducting research in the area of addictions with accompanying peer-reviewed publications.

• The Contractor must have experience in the provision of presentations on psychology-related topics.

• The Contractor must have and demonstrate experience and knowledge in the evaluation of drug treatment programs.

• The Contractor must have experience with data analysis and advanced statistics.

• The Contractor must have experience working collaboratively with other professionals in

SOW Drug Treatment Program Evaluation Page 11 of 15 the field as evidenced by joint grants, joint research, and/or joint presentations.

• The Contractor must demonstrate experience publishing articles in professional, peer-reviewed journals that describe the results of program evaluations including drug treatment programs.

• The Contractor must have experience conducting research in a prison setting.

3.2 CONTINUITY OF SUPPORT

The Contractor shall ensure that the contractually required level of support for this requirement is maintained at all times. The Contractor shall ensure that all contract support personnel are present Monday through Friday, 11:00 am – 4:00 pm Eastern.

3.3 KEY PERSONNEL

The Contractor shall hire key personnel to be approved by the BOP to meet SOW requirements.

The Contractor will identify the key personnel by name, position, and responsibility. The Contractor will staff all key personnel positions throughout the performance of the contract.

Before replacing any individual designated as Key by the Government, the Contractor shall notify the Contracting Officer no less than 15 business days in advance, submit written justification for replacement, and provide the name and qualifications of any proposed substitute(s). All proposed substitutes shall possess qualifications equal to or superior to those of the Key person being replaced, unless otherwise approved by the Contracting Officer. The Contractor shall not replace Key Contractor personnel without approval from the Contracting Officer. The following Contractor personnel are designated as Key for this requirement:

• Project Manager Note: The Government may designate additional Contractor personnel as Key at the time of award.

3.4 PROJECT MANAGER

The Contractor shall provide a Project Manager who shall be responsible for all Contractor work performed under this SOW. The Project Manager shall be a single point of contact for the Contracting Officer and the COR. It is anticipated that the Project Manager shall be one of the senior level employees provided by the Contractor for this work effort. The name of the Project Manager, and the name(s) of any alternate(s) who shall act for the Contractor in the absence of the Project Manager, shall be provided to the Government as part of the Contractor's proposal.

The Project Manager is further designated as Key by the Government. During any absence of the Project Manager, only one alternate shall have full authority to act for the Contractor on all matters relating to work performed under this contract. The Project Manager and all designated alternates shall be able to read, write, speak and understand English. Additionally, the Contractor shall not replace the Project Manager without prior approval from the Contracting Officer.

3.4.1 The Project Manager shall be available to the CO via telephone between the hours of 10:00 am and 3:00 pm EST, Monday through Friday, and shall respond to a request for discussion or resolution of technical problems within 48 hours of notification.

3.5 EMPLOYEE IDENTIFICATION

3.5.1 Contractor employees visiting on-site at Government facilities shall wear a Government issued identification badge. All Contractor employees shall identify themselves as Contractors when their status is not readily apparent (in meetings, when answering Government telephones, SOW Drug Treatment Program Evaluation Page 12 of 15 in e-mail messages, etc.) and display the Government issued badge in plain view above the waist at all times.

3.6 EMPLOYEE CONDUCT

Contractor’s employees shall comply with all applicable Government regulations, policies and procedures (e.g., fire, safety, sanitation, environmental protection, security, “off limits” areas, etc.) when visiting or working at Government facilities. The Contractor shall ensure Contractor employees present a professional appearance at all times and that their conduct shall not reflect discredit on the United States or the Department of Commerce. The Project Manager shall ensure Contractor employees understand and abide by Department of Commerce established rules, regulations and policies concerning safety and security.

3.7 REMOVING EMPLOYEES FOR MISCONDUCT OR SECURITY REASONS

The Government may, at its sole discretion (in coordination with the Contracting Officer where practical), direct the Contractor to remove any Contractor employee from BOP facilities for misconduct or security reasons. Removal does not relieve the Contractor of the responsibility to continue providing the services required under the contract. The Contracting Officer will provide the Contractor with a written explanation to support any request to remove an employee.

4.0 OTHER APPLICABLE CONDITIONS

4.1 SECURITY

Contractor access to unclassified, but Security Sensitive Information may be required under this SOW. Contractor employees shall safeguard this information against unauthorized disclosure or dissemination.

4.2 PERIOD OF PERFORMANCE

The period of performance for this contract is a one-year base period with four one-year option periods as follows:

Base Period September 1, 2021 through August 31, 2022 Option Period One September 1, 2022 through August 31, 2023 Option Period Two September 1, 2023 through August 31, 2024 Option Period Three September 1, 2024 through August 31, 2025 Option Period Four September 1, 2025 through August 31, 2026

4.3 PLACE OF PERFORMANCE

The primary place of performance will be the Contractor’s facilities. The Contractor will travel at least once per year to administrative offices in Grand Prairie, Texas, and once per year to administrative offices in Washington, D.C.

4.4 TRAVEL

Travel expenses will be included in the fixed fee for the task.

4.5 POST AWARD CONFERENCE

The Contractor shall attend a Post Award Conference with the Contracting Officer and the COR no later than 20 business days after the date of award. The purpose of the Post Award Conference, which will be chaired by the Contracting Officer, is to discuss technical and contracting objectives of this contract and review the Contractor's draft project plan. The Post Award Conference will be held via teleconference.

SOW Drug Treatment Program Evaluation Page 13 of 15

4.6 PROJECT PLAN

The Contractor shall provide a draft Project Plan at the Post Award Conference for Government review and comment. The Contractor shall provide a final Project Plan to the COR not later than 40 business days after the Post Award Conference.

4.7 PROGRESS REPORTS

The Project Manager shall provide a quarterly (i.e., every three months following contract award) progress report to the Contracting Officer and COR via electronic mail. This report shall include a summary of all Contractor work performed, including all deliverables invoiced, an assessment of technical progress, and any Contractor concerns or recommendations relevant to the reporting period.

4.8 PROGRESS MEETINGS

The Project Manager shall be available to meet with the COR upon request to present deliverables, discuss progress, exchange information and resolve emergent technical problems and issues. These meetings shall take place via teleconference.

4.9 GENERAL REPORT REQUIREMENTS

The Contractor shall provide all written reports in electronic format with read/write capability using applications that are compatible with BOP workstations (i.e., Microsoft Office Applications).

4.10 PROTECTION OF INFORMATION

Contractor employees shall safeguard sensitive information against unauthorized disclosure or dissemination in accordance with the Privacy Act, OMB M06-16 (PII) and other pertinent laws and regulations governing the confidentiality of privileged information and Safeguarding Sensitive But Unclassified (SBU) (For Official Use Only) Information.

5.0 GOVERNMENT TERMS & DEFINITIONS

COR Contracting Officer’s Representative BOP Bureau of Prisons PSB Psychology Services Branch RSD Reentry Services Division ORE Office of Research and Evaluation RRC Residential Reentry Center

NRDAP Non-Residential Drug Abuse Program RDAP Residential Drug Abuse Program MAT Medication Assisted Treatment

6.0 GOVERNMENT FURNISHED RESOURCES

The Government will not furnish facilities, property, equipment, supplies, or services to the Contractor in support of this contract. The Government will provide the following information, data and documents to the Contractor for work required under this contract:

• Treatment protocols

• Treatment records of program participants, including attendance, diagnostic, and progress information

• Demographic data (e.g., age, race, ethnicity, security level, etc.) as required by approved research design

SOW Drug Treatment Program Evaluation Page 14 of 15

• Institution adjustment data (e.g., incident reports of misconduct, work assignments, programming records, etc.)

• Pre- and post-assessment data, as required by approved research design

7.0 CONTRACTOR FURNISHED PROPERTY

The Contractor shall furnish all facilities, materials, equipment and services necessary to fulfill the requirements of this contract, except for the Government Furnished Resources specified in SOW 2.0 and SOW 6.0.

The Contractor must have access to the appropriate statistical software package (e.g., SPSS, SAS). The Contractor must have access to any personal (non-BOP) electronic resources for preparing and writing any component related to the research process (e.g., computer, printer, scanner). Any needs associated with either statistical software or electronic resources will be included in the fixed fee for the task.

8.0 GOVERNMENT ACCEPTANCE PERIOD

The COR will review deliverables prior to acceptance and provide the Contractor with an e-mail that provides documented reasons for non-acceptance. If the deliverable is acceptable, the COR will send an e-mail to the Contractor notifying it that the deliverable has been accepted.

8.1 The COR will have the right to reject or require correction of any deficiencies found in the deliverables that are contrary to the information contained in the Contractor’s accepted proposal. In the event of a rejected deliverable, the Contractor will be notified in writing by the COR of the specific reasons for rejection. The Contractor may have an opportunity to correct the rejected deliverable and return it per delivery instructions.

8.2 The COR will have 40 business days to review deliverables and make comments. The Contractor shall have 40 business days to make corrections and redeliver.

8.3 All other review times and schedules for deliverables shall be agreed upon by the parties based on the final approved Project Plan. The Contractor shall be responsible for timely delivery to Government personnel in the agreed upon review chain, at each stage of the review. The Contractor shall work with personnel reviewing the deliverables to assure that the established schedule is maintained.

9.0 DELIVERABLES

ITEM SOW

REFERENCE DELIVERABLE / EVENT DUE BY

DISTRIBUTION

1 4.5 Post Award Conference 20 business days after contract award

N/A

SOW Drug Treatment Program Evaluation Page 15 of 15

ITEM SOW

REFERENCE DELIVERABLE / EVENT DUE BY

DISTRIBUTION

2 4.6 Draft Contractor Project Plan

40 business days after the Post Award Conference

COR,

Contracting Officer

2.1.1, 2.2.1, 2.3.1, 2.4.1, 2.5.1

IRB Proposal 60 business days after the Post Award Conference

COR

4 4.7 Progress Reviews Quarterly, following contract award

COR,

Contracting Officer

2.1.4., 2.2.4,

2.3.4 2.4.4, 2.5.4

Written Presentation of Findings for Each Study Completed

30 days after completion of each study

COR

2.1.5, 2.2.5, 2.3.5, 2.4.5, 2.5.5

In-Person Presentation of Findings After All Studies are Completed

30 days after completion of the final written presentation of findings

COR

2.1.7, 2.2.7, 2.3.7, 2.4.7, 2.5.7

Written Information for Non-Scholarly Audiences After All Studies are Completed

30 days after completion of all studies

COR

References

First Step Act of 2018, Pub. L. No. 115-391, 18 U.S.C. § 3631, 132 Stat. 5194 (2018).

https://uscode.house.gov/statutes/pl/115/391.pdf